MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to…
Recall Z-0417-2015, part of FDA recall event 69545. See Diagnostic Hybrids's company page.
Diagnostic Hybrids Inc started this Class II device recall on Oct 16, 2014 (voluntary: firm initiated); FDA lists it as terminated, terminated Sep 3, 2015.
- Classification: Class II
- Started: Oct 16, 2014
- Status: Terminated
Samples are quantitating incorrectly, with approximately 50% higher concentration values than previously reported and historically documented.
- Product
- MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to perform the test. In vitro diagnostic.
- Quantity
- 171
- Lots and codes
- Model Number A027; Lot Number 018186; (self-affixed, EDMA Code: 12 01 02 04 00; Complement Component Bb)
- Distribution
- Worldwide Distribution - USA, including AL, CO, CT, FL, KY, MN, NC, NV, OH, PA, and WA; and, the countries of Canada, China, India, and Switzerland.
- Recalling firm
- Diagnostic Hybrids Inc, Athens, OH, United States
- How the firm notified
- Letter
- FDA classified
- Sep 3, 2015
Newest first, one product per recall event; search them all
- Diagnostic Hybrids, Inc., RhMK, Model #:49-0600, 49-0600A, 49-0102A, and 49-T075A. Culture media, used in the…Z-0792-2013 · Class III · Dec 31, 2012 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports